Invivyd, Inc.

General ticker "IVVD" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $117.5M (TTM average)

Invivyd, Inc. follows the US Stock Market performance with the rate: 41.0%.

Estimated limits based on current volatility of 4.2%: low 2.38$, high 2.59$

Factors to consider:

  • Total employees count: 95 (+10.5%) as of 2023
  • Top business risk factors: Lack of profitability, Cybersecurity threats, Disruption to business operations, Regulatory and compliance, Strategic risks and growth management
  • Current price 113.4% above estimated high
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.32$, 1.14$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.35$, 1.15$]

Financial Metrics affecting the IVVD estimates:

  • Positive: with PPE of -0.3 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Positive: 42.53 < Shareholder equity ratio, % of 52.15 <= 64.17
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Investing cash flow per share per price, % of -0.25 > -0.62
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term IVVD quotes

Long-term IVVD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $0.00MM $25.38MM
Operating Expenses $212.76MM $202.26MM
Operating Income $-212.76MM $-176.88MM
Non-Operating Income $14.12MM $6.95MM
R&D Expense $163.63MM $137.25MM
Income(Loss) $-198.64MM $-169.93MM
Profit(Loss)* $-198.64MM $-169.93MM
Stockholders Equity $177.47MM $67.54MM
Assets $229.18MM $129.51MM
Operating Cash Flow $-173.16MM $-170.49MM
Capital expenditure $0.61MM $0.14MM
Investing Cash Flow $280.68MM $-0.14MM
Financing Cash Flow $1.04MM $39.33MM
Earnings Per Share** $-1.81 $-1.43

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.